Antimicrobial metabolites from a marine-derived actinomycete in Vietnam's East Sea

Natural Product Communications

Volumn 11, Issue 1, 2016, Pages 49-51

  Thi, Quyen Vu ^a   Tran, Van Hieu ^a   Mai, Huong Doan Thi ^a   Le, Cong Vinh ^a   Hong, Minh Le Thi ^a   Murphy, Brian T ^b   Chau, Van Minh ^a   Pham, Van Cuong ^a  

^a Institute of Marine Biochemistry   (Viet Nam)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

2 (5 Methyl 1,4 dioxan 2 yl)methoxy ethanol; 3,4 Dihydroxy 6,7 dimethyl quinoline 2 carboxylic acid; Actinomycete; Antibacterial, Antifungal; Micromonospora sp G019

Indexed keywords

1,4 DIOXANE DERIVATIVE; 2 [(5 METHYL 1,4 DIOXAN 2 YL)METHOXY]ETHANOL; 3,4 DIHYDROXY 6,7 DIMETHYLQUINOLINE 2 CARBOXYLIC ACID; ALKALOID; ANTIINFECTIVE AGENT; NYSTATIN; STREPTOMYCIN; UNCLASSIFIED DRUG; 2-((5-METHYL-1,4-DIOXAN-2-YL)METHOXY)ETHANOL; 3,4-DIHYDROXY-6,7-DIMETHYL-QUINOLINE-2-CARBOXYLIC ACID; ALCOHOL; ALCOHOL DERIVATIVE; ANTIFUNGAL AGENT; DIOXANE DERIVATIVE; QUINOLINE DERIVATIVE;

ACTINOBACTERIA; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS CEREUS; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FRACTIONATION; MASS SPECTROMETRY; MICROMONOSPORA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; VIET NAM; ANALOGS AND DERIVATIVES; BACTERIUM; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SEA; SEDIMENT;

ACTINOBACTERIA; ALCOHOLS; ALKALOIDS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; CANDIDA ALBICANS; DIOXANES; ETHANOL; GEOLOGIC SEDIMENTS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; OCEANS AND SEAS; QUINOLINES; VIETNAM;

EID: 84973410769     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1601100116     Document Type: Article

References (20)

1. Fenical W. (1993) Chemical studies of marine bacteria: developing a new resource. Chemical Review, 93, 1673-1683.
2. Fenical W, Jensen PR. (2006) Developing a new resource for drug discovery: marine actinomycete bacteria. Nature Chemical Biology, 2, 666-673.
3. He H, Ding WD, Bernan VS, Richardson AD, Ireland CM, Greenstein M, Ellestad GA, Carter GT. (2001) Lomaiviticins A and B, potent antitumor antibiotics from Micromonospora lomaivitiensis. Journal of the American Chemical Society, 123, 5362-5363.
4. Sousa TdaS, Jimenez PC, Ferreira EG, Silveira ER, Braz-Filho R, Pessoa ODL, Costa-Lotufo LV. (2012) Anthracyclinones from Micromonospora sp.. Journal of Natural Products, 75, 489-493
5. Igarashi Y, Yanase S, Sugimoto K, Enomoto M., Miyanaga S., Trujillo ME, Saiki I., Kuwahara S. (2011) Lupinacidin C, an inhibitor of tumor cell invasion from Micromonospora lupini. Journal of Natural Products, 74, 862-865
6. Igarashi Y, Trujillo ME, Martínez-Molina E, Yanase S, Miyanaga S, Obata T, Sakurai H, Saiki I, Fujitad T, Furumai T. (2007) Antitumor anthraquinones from an endophytic actinomycete Micromonospora lupini sp. nov. Bioorganic & Medicinal Chemistry Letters, 17, 3702-3705
7. Yang SW, Chan TM, Terracciano J, Patel R, Loebenberg D, Chen G, Patel M, Gullo V, Pramanik B, Chu M. (2004) A new anthracycline antibiotic micromonomycin from Micromonospora sp. The Journal of Antibiotics, 57, 601-604
8. Furumai T, Igarashi Y, Higuchi H, Saito N, Oki T. (2002) Kosinostatin, a quinocycline antibiotic with antitumor activity from Micromonospora sp. TP-A0468. The Journal of Antibiotics, 55, 128-133.
9. Anzai Y, Sakai A, Li W, Iizaka Y, Koike K, Kinoshita K, Kato F. (2010) Isolation and characterization of 23-O-mycinosyl-20-dihydrorosamicin: a new rosamicin analogue derived from engineered Micromonospora rosaria. The Journal of Antibiotics, 63, 325-328
10. Ohta E, Kubota NK, Ohta S, Suzuki M, Ogawa T, Yamasaki A, Ikegami S. (2001) Micromonospolides A-C, new macrolides from Micromonospora sp. Tetrahedron, 3, 8463-8467
11. Kinumaki A, Harada KI, Suzuki T, Suzuki M, Okuda T. (1977) Macrolide antibiotics M-4365 produced by Micromonospora. II. Chemical structures. The Journal of Antibiotics, 30, 450-454
12. Wagman GH, Waitz JA, Marquez J, Murawaski A, Oden EM, Testa RT, Weinstein MJ. (1972) New Micromonospora-produced macrolide antibiotic, rosamicin. The Journal of Antibiotics, 25, 641-652.
13. Romero F, Espliego F, Pérez Baz J, García de Quesada T, Grávalos D, de la Calle F, Fernández-Puentes JL. (1997) Thiocoraline, a new depsipeptide with antitumor activity produced by a marine Micromonospora. I. Taxonomy, fermentation, isolation, and biological activities. The Journal of Antibiotics, 50, 734-737
14. Raja A, Prabakarana P. (2011) Actinomycetes and drugs-An overview. American Journal of Drugs Discovery and Development, 1, 75-84
15. Van-Dun JAJ, Wouters WBL, Janicot MMF, Mocek UM, Laakso JA. (2004) Bafilomycin-like metabolite from a novel Micromonospora species. WO 2004005311 A1 20040115.
16. Fattorusso E, Forenza S, Minale L, Sodano G. (1971) Isolation of 3,4-dihydroxyquinoline-2-carboxylic acid from the sponge Aplysina aerophoba. Gazzetta Chimica Italiana, 101, 104-105.
17. Thoms C, Ebel R, Hentschel U, Proksch P. (2003) Sequestration of dietary alkaloids by the spongivorous marine mollusc Tylodina perversa. Zeitschrift für Naturforschung, 58c, 426-432
18. Thoms C, Wolff M, Padmakumar K, Ebel R, Proksch P. (2004) Chemical defense of Mediterranean sponges Aplysina cavernicola and Aplysina aerophoba. Zeitschrift für Naturforschung, 59c, 113-122
19. Putz A, Kloeppel A, Pfannkuchen M, Brümmer F, Proksch P. (2009) Depth-related alkaloid variation in Mediterranean Aplysina sponges. Zeitschrift für Naturforschung, 64c, 279-287.
20. Andrews JM. (2001) Determination of minimum inhibitory concentrations. Journal of Antimicrobial Chemotherapy, 48, Suppl. S1, 5-16.